Annabel Meireson

Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma

Nora Sundahl, Teofila Seremet, Jo Van Dorpe et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 65 citations

Radiation Medicine, Surgical Oncology, Radiation Therapy +8

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma

Nora Sundahl, Katrien De Wolf, Vibeke Krüse et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 36 citations

Surgical Oncology, Radiation Therapy, Dose Escalation Trial +7

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

Nora Sundahl, Katrien De Wolf, Sylvie Rottey et al. · Journal of Translational Medicine · 2017 · 35 citations · Full text

Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

Annabel Meireson, Inès Chevolet, Eva Hulstaert et al. · Oncotarget · 2018 · 28 citations · Full text

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas, Nora Sundahl, Eva Hulstaert et al. · BMC Cancer · 2021 · 18 citations · Full text